Michael A. Jacobsen
2012 - Sarepta Therapeutics
Compensation breakdown
Non-Equity Incentive Plan | $97,500 |
---|---|
Option Awards | $365,158 |
Salary | $283,333 |
Stock Awards | $75,600 |
Other | $10,366 |
Total | $831,957 |
Jacobsen received $365.2K in option awards, accounting for 44% of the total pay in 2012.
Jacobsen also received $97.5K in non-equity incentive plan, $283.3K in salary, $75.6K in stock awards and $10.4K in other compensation.
Rankings
In 2012, Michael A. Jacobsen's compensation ranked 6,859th out of 11,487 executives tracked by ExecPay. In other words, Jacobsen earned more than 40.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,859 | 40th |
Manufacturing | 2,457 | 42nd |
Chemicals And Allied Products | 624 | 48th |
Drugs | 427 | 54th |
Pharmaceutical Preparations | 334 | 52nd |
Jacobsen's colleagues
We found seven more compensation records of executives who worked with Michael A. Jacobsen at Sarepta Therapeutics in 2012.
2012
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
2012
David Howton
Sarepta Therapeutics
General Counsel
2012
David Howton
Sarepta Therapeutics
General Counsel
2012
Christopher Garabedian
Sarepta Therapeutics
Chief Executive Officer
2012
Edward Kaye
Sarepta Therapeutics
Chief Executive Officer
2012
Jayant Aphale
Sarepta Therapeutics
Senior Vice President, Technical Operations
2012
Effie Toshav
Sarepta Therapeutics